Academic Journal
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
| العنوان: | Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort. |
|---|---|
| المؤلفون: | Ciccullo, Arturo, Baldin, Gianmaria, Cervo, Adriana, Moschese, Davide, Lagi, Filippo, Cossu, Maria Vittoria, Grimaldi, Alessandro, Giacomelli, Andrea, Rusconi, Stefano, Sterrantino, Gaetana, Borghetti, Alberto, Antinori, Spinello, Mussini, Cristina, Di Giambenedetto, Simona |
| المصدر: | J Antimicrob Chemother ; ISSN:1460-2091 ; Volume:80 ; Issue:1 |
| بيانات النشر: | Silverchair Information Systems |
| سنة النشر: | 2025 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | We compared the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) and dolutegravir plus lamivudine (DTG + 3TC) in our cohort of treatment-naive people with HIV (PWH). |
| نوع الوثيقة: | article in journal/newspaper report |
| اللغة: | English |
| Relation: | https://doi.org/10.1093/jac/dkae392; https://pubmed.ncbi.nlm.nih.gov/39478330 |
| DOI: | 10.1093/jac/dkae392 |
| الاتاحة: | https://doi.org/10.1093/jac/dkae392 https://pubmed.ncbi.nlm.nih.gov/39478330 |
| Rights: | © The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. |
| رقم الانضمام: | edsbas.9F687447 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/jac/dkae392 |
|---|